Verition Fund Management LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Verition Fund Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $153,594 - $242,316	95,400 Added 235.56%	135,900 $245,000
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.95 $26,333 - $45,045	23,100 Added 132.76%	40,500 $75,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $33,214 - $60,617	-27,679 Reduced 61.4%	17,400 $23,000
Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $8,609 - $18,592	-5,282 Reduced 10.49%	45,079 $76,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $2,190 - $11,220	3,000 Added 6.33%	50,361 $157,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $19,316 - $36,876	8,780 Added 22.76%	47,361 $113,000
Q1 2022 May 13, 2022	BUY	$2.83 - $8.69 $24,284 - $74,568	8,581 Added 28.6%	38,581 $155,000
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $274,500 - $398,400	30,000 New	30,000 $348,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.